CMC Biologics Announces Appointment of New CEO
Claes Glassell, former CEO of Cerus Corporation, to Take Helm
CMC Biologics announced that it has hired Claes Glassellto serve at its Chief Executive Officer. CMC Biologics, a company with 370 employees, is committed to delivering world class, fully integrated, biopharmaceutical process development and manufacturing services. Claes Glassellbrings more than 30 years of industry experience to CMC, most recently as CEO of Cerus Corporation and prior to that as President of Cambrex Corp.
Claes Glassell joined the CMC board of directors in 2005. Claes left the position as President & CEO of Cerus Corporation, Inc. to take on the position as CEO of CMC Biologics. He is the former President of Cambrex Corporation, Inc. and has previously held senior positions with Akzo Nobel NV, Nobel Industries AB and Berol Kemi AB. His areas of expertise include 20 years of executive positions in publicly listed Life Sciences companies responsible for bioprocessing, active ingredients business, registered therapeutic agents and various support services.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
